A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

Clinical trial NCT06561425 · TERMINATED

Trial details

NCT number: NCT06561425
Sponsor: Lakefront Biotherapeutics NV
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory B-cell Non-Hodgkin Lymphoma Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell

Start date: 2022-03-09
Primary completion: 2026-05-27
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.